Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.23.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Total revenue $ 19,754 $ 38,697
Operating expenses:    
Research and development 82,425 84,665
General and administrative 26,200 34,106
Total operating expenses 108,625 118,771
Loss from operations 88,871 80,074
Interest and other income, net 988 434
Interest and other expense, net (4,782) (3,369)
Loss before provision for income taxes 92,665 83,009
Provision for income taxes 53 0
Net loss 92,718 83,009
Net loss attributable to common shareholders $ 92,718 $ 83,009
Net loss per share attributable to common shareholders:    
Basic $ 1.65 $ 1.50
Diluted $ 1.65 $ 1.50
Weighted average number of shares used in net loss per share calculations:    
Basic 56,334,456 55,297,798
Diluted 56,334,456 55,297,798
Provision for income taxes $ (53) $ 0
Research And Development Revenue, Related Party    
Total revenue 0 13,136
Research And Development Revenue, Other    
Total revenue $ 19,754 $ 25,561